NE Stock Recent News

CULVER CITY, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment, today announced that its Co-Chief Executive Officer, Tony Tian, and Chief Financial Officer, Heidy Chow, will present at NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL, on Tuesday, December 3rd at 1:00 PM EST.

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will present at the upcoming Noble Capital Markets' 20th Annual Emerging Growth Equity Conference on December 3-4, 2024, in Boca Raton, FL.

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place on December 3, 2024. CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event and will host a presentation for in-person attendees.

GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that the Company's management will be attending and presenting at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place December 3-4, 2024, in Boca Raton, Florida.

24/7 Wall St. Insights As we race toward the end of the year, the past week brought some huge insider share purchases.

INDIANAPOLIS, IN / ACCESSWIRE / November 13, 2024 / Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub ("CPP"), today announced financial data for the third quarter 2024 and other company highlights. Financial highlights from the 3rd quarter 2024 include: Net Income of $193,000 Operating Income of $417,000 Franchising Revenue of $1.4 million compared to $1.3 million in 2023 Same store sales for company-owned CPP restaurants increased almost 1% Average store sales for company-owned CPP restaurants for the last 6 operational weeks (prior to this release date) increased approximately 5.2% over the same operational weeks in 2023 Cost of sales in the Craft Pizza & Pub increased from 19.8% to 21.4% due primarily to elevated cheese prices and the promotion of the company's value-oriented XL Pizza Labor in the Craft Pizza & Pub decreased from 29.6% to 28.8% despite market pressures on management salaries F

INDIANAPOLIS, IN / ACCESSWIRE / November 13, 2024 / Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub, announced that it will report 2024 3rd quarter financial data on Wednesday, November 13th after the markets close. Noble Roman's also announced that it will host a conference call on Thursday, November 14th from 4:00 to 4:45 PM EST.

ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company. The full report by Noble Capital Markets Research Analyst Robert LeBoyer, as well as news and advanced market data on Zomedica Corp., is available on Channelchek.

Noble Capital raised the firm's price target on Graham to $45 from $35 and keeps an Outperform rating on the shares. Graham's Q2 results exceeded expectations as "strong" sales growth, along with "exceptional execution throughout the business," drove meaningful margin expansion, the analyst tells investors. The balance sheet "remained stellar" and Graham raised full year gross margin and adjusted EBITDA estimates, the analyst added.

Noble Corporation's geographic diversification and strong client base are positives, but its lack of long-term contracts and idle rigs are concerning. The company's fluctuating revenues and earnings, coupled with high operating costs for idle rigs, present significant financial risks. Despite the attractive valuation, unpredictable oil prices and delayed contract executions make future earnings uncertain.